NextGen Healthcare (NASDAQ:NXGN) issued an update on its FY21 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.92-0.98 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.90. The company issued revenue guidance of $547-555 million, compared to the consensus revenue estimate of $546.79 million.NextGen Healthcare also updated its Q3 guidance to $0.24-0.26 EPS.
Several equities analysts have recently issued reports on the company. Colliers Securities reissued a buy rating on shares of NextGen Healthcare in a report on Friday, December 11th. Morgan Stanley upped their price target on shares of NextGen Healthcare from $12.00 to $14.00 and gave the stock an underweight rating in a research report on Monday, October 26th. SVB Leerink lifted their target price on shares of NextGen Healthcare from $12.00 to $14.00 and gave the stock a market perform rating in a research note on Friday, October 23rd. Cantor Fitzgerald increased their price target on NextGen Healthcare from $13.00 to $15.00 and gave the company a neutral rating in a report on Friday, October 23rd. Finally, BidaskClub raised shares of NextGen Healthcare from a hold rating to a buy rating in a research note on Thursday, October 8th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the company’s stock. NextGen Healthcare presently has a consensus rating of Hold and an average price target of $13.13.
Shares of NASDAQ:NXGN opened at $20.47 on Wednesday. The company has a market cap of $1.37 billion, a P/E ratio of 127.95, a PEG ratio of 3.33 and a beta of 1.23. The business’s 50-day simple moving average is $18.30 and its 200 day simple moving average is $14.55. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.64 and a current ratio of 1.64. NextGen Healthcare has a one year low of $5.10 and a one year high of $20.59.
In other news, Director George H. Bristol sold 4,800 shares of the company’s stock in a transaction that occurred on Thursday, December 3rd. The shares were sold at an average price of $17.52, for a total value of $84,096.00. Following the completion of the sale, the director now directly owns 67,061 shares of the company’s stock, valued at approximately $1,174,908.72. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 18.70% of the company’s stock.
About NextGen Healthcare
NextGen Healthcare, Inc provides ambulatory-focused healthcare software and services solutions in the United States. The company offers NextGen Enterprise electronic health record (EHR), which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Featured Story: Resistance Level
Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.